We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
BIOCON.NSE

Price
316.55
Stock movement up
+10.25 (3.35%)
Company name
Biocon Limited
Exchange
(NSE
,
Currency
INR
)
Sector
Healthcare >
Biotechnology
Market cap
379.12B
Ent value
666.32B
Price/Sales
2.62
Price/Book
1.42
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
26.34
Forward P/E
39.57
PEG
-
EPS growth
2.36%
1 year return
15.61%
3 year return
-3.19%
5 year return
1.91%
10 year return
16.51%
Last updated: 2025-04-12

DIVIDENDS

BIOCON.NSE does not pay dividends or no data was received

VALUATION

Valuation Ratios

Valuation Ratios data
Trailing P/E26.34
Price to OCF45.73
Price to FCF45.73
Price to EBITDA25.82
EV to EBITDA45.38

Valuation (Sales/Book Value)

Valuation (Sales/Book Value) data
Price to Sales2.62
Price to Book1.42
EV to Sales4.61

FINANCIALS

Per share

Per share data
Current share count1.20B
EPS (TTM)11.69
FCF per share (TTM)6.74

Income statement

Income statement data
Revenue (TTM)144.44B
Gross profit (TTM)73.14B
Operating income (TTM)19.99B
Net income (TTM)14.39B
EPS (TTM)11.69
EPS (1y forward)8.00

Margins

Margins data
Gross margin (TTM)50.63%
Operating margin (TTM)13.84%
Profit margin (TTM)9.96%

Balance Sheet

Please create a free account or log in to access this chart
Balance Sheet data
Cash16.88B
Net receivables61.29B
Total current assets151.53B
Goodwill164.67B
Intangible assets102.25B
Property, plant and equipment0.00
Total assets571.28B
Accounts payable63.69B
Short/Current long term debt167.71B
Total current liabilities158.05B
Total liabilities304.08B
Shareholder's equity267.20B
Net tangible assets0.00

Cash flow

Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)8.29B
Capital expenditures (TTM)0.00
Free cash flow (TTM)8.29B
Dividends paid (TTM)0.00

Financial returns

Please create a free account or log in to access this chart
Financial returns data
Return on Equity5.39%
Return on Assets2.52%
Return on Invested Capital4.64%
Cash Return on Invested Capital2.68%

STOCK INFORMATION

Stock chart

Stock price data
Open320.00
Daily high323.00
Daily low313.60
Daily Volume3.06M
All-time high483.60
1y analyst estimate342.83
Beta0.46
EPS (TTM)11.69
Dividend per share-
Ex-div date4 Jul 2024
Next earnings date-

Downside potential

Downside potential data
BIOCON.NSES&P500
Current price drop from All-time high-34.54%-12.89%
Highest price drop-73.92%-56.47%
Date of highest drop1 Dec 20089 Mar 2009
Avg drop from high-26.04%-11.07%
Avg time to new high41 days12 days
Max time to new high1582 days1805 days
COMPANY DETAILS
BIOCON.NSE (Biocon Limited) company logo
Marketcap
379.12B
Marketcap category
Large-cap
Description
Biocon Limited, together with its subsidiaries, engages in the manufacture and sale of biotechnology products and research services in India, Brazil, Singapore, and internationally. It operates through four segments: Generics, Novel Biologics, Biosimilars, and Research Services. The company offers generic formulations and API products, including anti-diabetics, immunosuppressants, multiple sclerosis, anti-cancer/oncology, and other products; novel biologics products, such as head and neck cancer molecule; novel pipeline products comprising psoriasis molecules; and biosimilars products consisting of insulins, trastuzumab, pegfilgrastim, and bevacizumab. It also provides integrated discovery, development, and manufacturing services to pharmaceutical, biotechnology, animal healthcare, consumer good, and agrochemical companies. Biocon Limited was incorporated in 1978 and is headquartered in Bengaluru, India.
Employees
16315
Website
https://www.biocon.com
Investor relations
-
SEC filings
BIOCON.NSE SEC filings
CEO
Country
India
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
UNDERSTAND THE BUSINESS
COMPANY NEWS
All newsPress releases
No items found
Disclaimer
Skyfall Technology OÜ assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness or timeliness. Please also note, that any action you take upon the information provided on this website is strictly at your own risk. This website is intended to be used and must be used for informational purposes only and you should take independent financial advice from a professional and independently research and verify everything you see on the site.
Menu
HomePortfolio ManagementCompany ScreenerGreen InvestmentExchangesContact Us
Language
ENHUNOSVDAFIESDENLFRITPTPLCSSKROELTRRUAF
© 2024 Skyfall Technology OÜ All Rights Reserved